Member Info for Gray00143

That is the funding sorted, this should get them over the line, although I think something more is going to out either before or at the AGM with regards to a licensing, partnership or take over deal.

Around 2017, Zacks target price was £3.75 i Initially bought in ay £1.20 and have topped up each time the value has gone down. Things can change very quickly on AIM. They are now much more advanced than then with there tech. I do believe it's only the future funding that is holding the share price back.

lol come on girls calm down, we all want to come out of this well. It's been frustratingly slow, but that is the nature of the business . One feels this could take off at any moment. I still think we need to know how they are going to be funded after q4. I am however very confident that this tech is now to advanced to be ignored.

Good point SP28, why aren't the directors loading up?

That was a really good interview, all be it an old one, things have significantly moved on since then. Especially with last weeks news. I'm expecting some very positive news maybe on the day of the AGM about funding ect. Once this uncertainty is cleared up I would imagine the share price to double and hold going forward. If investors don't know where the funding is coming from after q4 it's hardly surprising they are selling up possibly taking little gains.

I would imagine a share placing is inevitable in the next few months , as Midatech simply has to raise more revenue to keep going. They are so close with this tech to fail at the 11th hour would be such a shame. The share price dropping & the tech involved , this must now be a very tempting buy out proposition for the global medical companies.

This news was just a pre cursor to much bigger news , which I would expect just before or at the AGM on the 30th June. Expect a major RNS that morning before the AGM starts at 11.30 am

This time last year we were at 89p , what is fair value ? this tech is worth billions if brought to market successfully.

A very positive update, But! Secure Bio, playing games at such a critical time, they obviously know that Midatech have something very big here , & they want a bigger slice of the cake. But such demands at this stage could bring the whole project and midatech down. Totally irresponsible on the part of Secure Bio. Or a deliberate attempt to sabotage Midatech progress.

Get out while you can, the court case will leave the whole group bankrupt and nobody will come out winners except the doorstep borrowers whose debt will be written off. simply because it has become to expensive for companies to collect.

Fantastic news from Kier , debts finally sorted out once and for all, senior management have taken a sword to costs over the last few years, this is now a lean , efficient company, and with the government set to announce even more massive infrastructure projects in the next month, Kier should be a healthy beneficiary. This lets hope management keeps a tight reign on costs going forward.

After many years of dithering finally we get decisive management, better late than never, this should have happened years ago, it's been obvious for some time there is no money to be made out of doorstep lending.
Delighted to hear that Moneybarn will be cranked up, & that makes sense, as the economy booms as we get back to normal, people will be spending on cars, already you can see on our roads lots of new cars being bought. And 95% of all new cars on the road are through finance companies such as moneybarn.

This news is about time, hopefully now PFG can move on to better times, this was inevitable after the last FCA investigation was announced. Doorstep lending is a mugs game. But.. I'm afraid it opens up the door to the criminal gangs and heavies on the street corner as in the bad old days & the blame there lies with the FCA who with there constant upholding off complains has pushed these lenders to far. And the very customers that have complained will be the ones to suffer in the long term.

An absolute disaster, very comprehensive RNS , but nothing positive to be gained in it, in fact the stark admission that more fund raising will be required later this year, & more alarming is the fact that they say they may well not be able to carry on as a going concern.

That is a worry , results complete and dead silence , that indicates to me that there is some somber thinking going on. After all with positive results they would be shouting from the roof tops.

A mask alone is all this company has, & it's too late to market, the vaccine rollout is very well under way, and the world is awash already with good quality masks. This mask is nothing special. Other manufactures will instantly be able to add an extra layer if they see fit.

Q1 has now passed & the promised news did not arrive in & shape or form, I'm expecting imminent news anytime time now, what it is will be anybody's guess . Clarity is needed , i hope its positive.

Shops to relax the wearing of face masks . Thought this would happen, I fear by the time RMS get production going it will be to late. they are reliant on new strains mutating , maybe the need is there for an export market, but I'm very skeptical that a mask alone can kill a virus. That is a very bold claim, which is false would lead to all sorts of law suits.

There are no vacancies , but it begs the question, have these positions been filled or the jobs scrapped going forward. These were major rolls , yet they the company hasn't named one person in the filling off these rolls. My guess is they could not get anyone for these positions and they are going to muddle through as best they can.

I'm topping up too, although it's slow progress , there is movement forward , usually one RNS is followed by another soon after. Could be waiting for the markets to digest the 1st RNS